pinned aminos semaglutide Structural Biophysics-Guided Computational Design of Analogues to Enhance GLP-1R Activation - Article (Preprint v1) by Wei Li Redefining peptide therapeutics with semaglutide

Abstract Diabetes and obesity are growing problems worldwide and are associated with a range of acute and chronic complications, including acute myocardial infarction (AMI) and stroke

Those who were concurrently using GLP-1 receptor agonists had a 48% lower rate of UTIs (8.8% versus 13.3%) and a 74% lower rate of urinary retention compared to those not on GLP-1 therapy

In the past ten years, a series of Phase III trials showed that the synthetic GLP-1/GIP agonists are effective in lowering blood sugar in type 2 diabetic subjects who were both treatment-nave or on typical first-line therapies such as metformin and insulin

Rezpegaldesleukin is a first-in-class IL-2 (Interleukin-2) pathway therapy that selectively expands regulatory T cells

While orlistat might have desirable effects in the management of obesity, its effectiveness is relatively modest